News & Events
Meet selectION Inc. at this years Biocom Global Life Science Partnering Conference in San Diego on February 28th
Andreas Klosterman, Ph.D. (CEO) will give an update on selectION’s best-in-class ion channel antagonists and discuss the principles of the company’s systematical peptide design to obtain the most selective and specific ion channel blockers.
- Meet selectION, Inc. at the Global Life Science Partnering & Investor Conference in La Jolla, CA, on February 27th to 29th, 2024
- selectION, Inc. to Present Update on Clinical Progress at the 42ndAnnual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2024
- Meet selectION, Inc. at the 42ndAnnual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 8th to 11th, 2024